Kevin Lafferty and the lymphocyte costimulator: theory and practice in Canberra
Immunology & Cell Biology · 2023
DOI: 10.1111/imcb.12683 ↗Kurz gefasst
Historischer Beitrag in der Zeitschrift Immunology & Cell Biology, 2023. Verfasst von Philip D Hodgkin. Beteiligte Einrichtung: Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. Hauptthemen laut MEDLINE: Allergy and Immunology, Lymphocyte Activation, T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Between 1969 and 1983 the lab of Kevin Lafferty in Canberra developed the concept of the T‐cell “costimulator,” an essential second signal for activation. A great deal of the work appeared in this journal before it was known as Immunology & Cell Biology ( ICB ). As part of the 100‐year anniversary of the journal, I offer a personal reflection on Kevin's legacy and impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
- Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.
ORCID-Profile: Philip D Hodgkin
Förderung
- National Health and Medical Research Council
Zitieren
APA
Hodgkin, P. D. (2023). Kevin Lafferty and the lymphocyte costimulator: theory and practice in Canberra. Immunology & Cell Biology. https://doi.org/10.1111/imcb.12683
Vancouver
Hodgkin PD. Kevin Lafferty and the lymphocyte costimulator: theory and practice in Canberra. Immunology & Cell Biology. 2023. doi:10.1111/imcb.12683
BibTeX
@article{Hodgkin2023,
author = {Hodgkin, Philip D},
title = {Kevin Lafferty and the lymphocyte costimulator: theory and practice in Canberra},
journal = {Immunology & Cell Biology},
year = {2023},
doi = {10.1111/imcb.12683}
}
EUVIMED